HAX1 and breast cancer: 46 breast cancer patients who were free of distant metastasis at the time of surgery and received no neoadjuvant therapy were retrospectively analyzed for HAX1 protein levels (cytoplasmic and nuclear) in primary tumors by immunohistochemistry.